Compound Summary
allantoin
Compound Information
allantoin
Compound Name: | allantoin |
Compound CID: | 204 |
Synonyms: | allantoin 97-59-6 5-Ureidohydantoin Glyoxyldiureide 1-(2,5-dioxoimidazolidin-4-yl)urea More... |
Iupac Name: | (2,5-dioxoimidazolidin-4-yl)urea |
InChI: | InChI=1S/C4H6N4O3/c5-3(10)6-1-2(9)8-4(11)7-1/h1H,(H3,5,6,10)(H2,7,8,9,11) |
InChIKey: | POJWUDADGALRAB-UHFFFAOYSA-N |
Canonical Smiles: | C1(C(=O)NC(=O)N1)NC(=O)N |
Isomeric Smiles: | C1(C(=O)NC(=O)N1)NC(=O)N |
Molecular Weight: | 158.12 |
Molecular Formula: | C4H6N4O3 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
allantoin
Molecular Weight: | 158.12 |
Molecular Formula: | C4H6N4O3 |
Hydrogen Bond Donor Count: | 4 |
Hydrogen Bond Acceptor Count: | 3 |
Rotatable Bond Count: | 1 |
Heavy Atom Count: | 11 |
Complexity: | 225 |
Synonyms
allantoin
| allantoin | allantoin |
|---|---|
allantoin |
97-59-6 |
5-Ureidohydantoin |
Glyoxyldiureide |
1-(2,5-dioxoimidazolidin-4-yl)urea |
Glyoxyldiureid |
Allantol |
Cordianine |
Sebical |
Alantan |
AVC/Dienestrolcream |
Urea, (2,5-dioxo-4-imidazolidinyl)- |
Hydantoin, 5-ureido- |
Cutemol emollient |
Uniderm A |
(2,5-Dioxo-4-imidazolidinyl)urea |
Glyoxylic diureide |
Glyoxylic(acid) diureide |
NSC 7606 |
Psoralon |
Septalan |
Caswell No. 024 |
(2,5-dioxoimidazolidin-4-yl)urea |
5-Ureido-2,4-imidazolidindion |
N-(2,5-Dioxo-4-imidazolidinyl)urea |
CCRIS 1958 |
2,5-Dioxo-4-imidazolidinyl-urea |
Fancol TOIN |
5-Ureidohydrantoin |
EPA Pesticide Chemical Code 085701 |
C4H6N4O3 |
4-ureido-2,5-Imidazolidinedione |
AI3-15281 |
NSC7606 |
Allantoin (JAN/USP) |
MFCD00005260 |
N-(2,5-dioxoimidazolidin-4-yl)urea |
97-59-6 (racemic) |
urea, N-(2,5-dioxo-4-imidazolidinyl)- |
MLS000737882 |
5-Ureido-2,4-imidazolidindione |
CHEBI:15676 |
DSSTox_CID_43 |
Herpecin L |
D00121 |
DSSTox_RID_75334 |
DSSTox_GSID_20043 |
Allantoin USAN:BAN |
SMR000528073 |
amino-N-(2,5-dioxo(1,3-diazolidin-4-yl))amide |
SR-01000766252 |
EINECS 202-592-8 |
BRN 0102364 |
Allantoi |
DL-Allantoin |
HSDB 7490 |
Allantoin USAN:USP:BAN:JAN |
CAS-97-59-6 |
Prestwick_11 |
NCGC00016358-01 |
Allation,(S) |
5-ureido-Hydantoin |
Allantoin (8CI) |
(+/-)-Allantoin |
Spectrum_001078 |
ACMC-209twn |
Prestwick0_000002 |
Prestwick1_000002 |
Prestwick2_000002 |
Prestwick3_000002 |
Spectrum2_000219 |
Spectrum3_000876 |
Spectrum4_000716 |
Spectrum5_001526 |
bmse000437 |
EC 202-592-8 |
SCHEMBL3208 |
Oprea1_621175 |
BSPBio_000003 |
BSPBio_002551 |
KBioGR_001271 |
KBioSS_001558 |
5-25-15-00338 (Beilstein Handbook Reference) |
MLS002473300 |
Allantoin, analytical standard |
DivK1c_000281 |
SPECTRUM1500801 |
Allantoin-13C2,15N4 |
SPBio_000237 |
SPBio_001924 |
BPBio1_000005 |
CHEMBL593429 |
DTXSID3020043 |
5-Ureidohydantoin;Glyoxyldiureide |
HMS500O03 |
KBio1_000281 |
KBio2_001558 |
KBio2_004126 |
KBio2_006694 |
KBio3_002051 |
Allantoin, >=98.0% (N) |
NINDS_000281 |
Urea,5-dioxo-4-imidazolidinyl)- |
HMS1568A05 |
HMS1921I10 |
HMS2092K16 |
HMS2095A05 |
HMS2268N08 |
HMS3712A05 |
HMS3885M08 |
Pharmakon1600-01500801 |
AMY13912 |
BCP31832 |
component of Skin-balm (Salt/Mix) |
HY-N0543 |
NSC-7606 |
2,5-Imidazolidinedione, 4-ureido- |
Tox21_110395 |
Tox21_202087 |
Tox21_302912 |
BBL027508 |
CCG-39781 |
NSC757792 |
s3856 |
SBB003997 |
STL373778 |
AKOS000120642 |
AKOS016038547 |
Tox21_110395_1 |
CS-7741 |
DB11100 |
MCULE-1008326286 |
NSC-757792 |
SDCCGMLS-0066595.P001 |
1-(2,5-Dioxoimidazolidin-4-yl);urea |
IDI1_000281 |
Allantoin, p.a., 98.5-101.0% |
N-(2,5-Dioxo-4-imidazolidinyl)urea # |
NCGC00094854-01 |
NCGC00094854-02 |
NCGC00094854-03 |
NCGC00094854-04 |
NCGC00094854-05 |
NCGC00094854-07 |
NCGC00256403-01 |
NCGC00259636-01 |
(RS)-(2,5-dioxoimidazolidin-4-yl)urea |
AC-11040 |
AS-13865 |
H736 |
NCI60_041675 |
N-(2,5-Dioxo-4(1h)-imidazolidinyl)urea |
SBI-0051759.P002 |
A0211 |
AB00052307 |
FT-0604592 |
ST50308144 |
C01551 |
D85069 |
J10470 |
Urea, (2,5-dioxo-4-imidazolidinyl)- (9CI) |
AB00052307_11 |
Q409804 |
J-522839 |
SR-01000766252-2 |
SR-01000766252-3 |
SR-01000766252-4 |
W-100104 |
Allantoin, European Pharmacopoeia (EP) Reference Standard |
A999F0D6-0285-41D9-A6BA-B705987B663C |
Allantoin, United States Pharmacopeia (USP) Reference Standard |
Allantoin, Pharmaceutical Secondary Standard; Certified Reference Material |
5-Ureidohydantoin; Glyoxyldiureide; Glyoxylic diureide; Cordianine; Glyoxyldiureid; (2,5-Dioxo-4-imidazolidinyl)urea |
Experimental Data
allantoin
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 250.000000000000000 | umol/L | 20.100000000000000 | S | N2 | 33683565 | Active | ||||||
| Caenorhabditis elegans | 250.000000000000000 | umol/L | 23.140000000000000 | 28.320000000000000 | 21.860000000000000 | S | N2 | 26676933 | Active | ||||
| Caenorhabditis elegans | 500.000000000000000 | umol/L | 14.300000000000000 | S | N2 | 33683565 | Active |
Experimental Data Visualization
allantoin
Statistics Data
allantoin
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | 21.860000000000000 | 2 | 3 |
Statistics Data Visualization
allantoin
